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ABSTRACT
MUTAGENIC AND TUMOR SUPPRESSOR FUNCTIONS OF DNA POLYMERASE
IOTA IN MAMMALIAN CELLS
Lindsey Jay Stallons
August7,2008
The Y family of DNA polymerases in higher eukaryotes contains at least four
members which are implicated in potentially error-prone replication through unrepaired
damage in the genome. These proteins are encoded by the REV1, POLH, POLl, and
POLK genes. An inherited deficiency in one of these DNA polymerases (POLr)) is the

molecular defect in the cancer prone xeroderma pigmentosum (XP) variant syndrome,
making POLr) the most studied member of this family. However, there exist critical gaps
in our knowledge on the function of the other known Y family members (POL

I,

POL

K,

and REV1). The goal of this proposal is to investigate the in vivo function of DNA POLl,
and the hypothesis that DNA polymerase I acts as a mutagenic polymerase in
translesion synthesis and as a tumor suppressor through a separate mechanism. To
test this hypothesis, the mutagenic effects of chemical carcinogens which form
structuallY different adducts will be examined in cells lacking POLr) and/or POLL To
characterize the tumor suppressor function(s) of POLl, cell cycle progression will be
monitored after UV in POLl null cells along with global gene expression. Finally, a novel
mouse model will be used to determine the effect of polr) and/or poll deficiency on UVand chemically-induced skin cancer.
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CHAPTER 1

INTRODUCTION
The Y family of DNA polymerases in higher eukaryotes contains at least four
members that are implicated in potentially error-prone replication through unrepaired
damage in the genome. These proteins are encoded by the REV1, POLfl, POLl, and

POLK genes. An inherited deficiency in one of these DNA polymerases (POLI1) is the
molecular defect in the cancer prone xeroderma pigmentosum (XP) variant syndrome,
making POLI1 the most studied member of this family. However, there exist critical gaps
in our knowledge on the function of the other known Y family members (POLl, POLK,
and REV1). Our goal is to investigate the cellular function of DNA POLl, and we
hypothesize that DNA polymerase I acts as a mutagenic polymerase in translesion
synthesis and as a tumor suppressor through a separate mechanism. This hypothesis is
based on the following observations. First, in vitro studies with purified POLl have
characterized its error-prone bypass of damaged DNA templates. Second, our group
and others have shown that POLl is active in error-prone bypass of UV damage in vivo.
Third, PO/fl-/- po/,-/- double knockout mice develop tumors faster than PO/fl-/- po/i+/+ single
knockouts despite having lower UV-induced mutation frequencies in their fibroblasts.
Based on these observations, the focus of this thesis is on the cellular function of DNA
POLL
In Chapter 2, we will evaluate the mutagenic properties of chemical carcinogens
in mammalian fibroblasts deficient for Y-family polymerases. We will examine the
differential cytotoxic and mutagenic response of human and mouse fibroblasts with
1

decreased expression of POLl") and/or POLl to benzo[a]pyrene-7,8-diol-9,10-epoxide
(BPDE), and N-acetoxy-2-acetylaminofluorene (AAAF). These chemicals form adducts
at different positions in the DNA, and this Chapter is proposed to determine the cellular
participation of each polymerase in bypassing chemically and structurally different DNA
lesions.
Chapter 3 is designed to investigate the tumor suppressor role of murine poll.
We propose to test the hypothesis that poll functions as a tumor suppressor in mouse
cells. Our group showed that mice that are deficient in both polf] and poll have lower
UV-induced mutation frequencies, but strikingly develop tumors faster than mice that are
deficient in polf] alone. This unexpected result is contrary to the somatic mutation
hypothesis of cancer and implies that poll has tumor suppressor activity that may be
independent of its mutagenic TLS activity. To investigate this, we propose to examine
the effect of poll deficiency on miRNA, gene expression, and cell cycle checkpoints
induced by UV or genotoxic carcinogens.
Finally, we will characterize the effect of poll deficiency on in vivo skin
tumorigenesis using a novel mouse model in Chapter 4. We hypothesize that deficiency
in poll alone is sufficient to promote progression of skin cancer caused by UV and
benzo[a]pyrene (B[a]P). Previous studies using C57BU6J mice required UV treatment
for 20 weeks, after which neither wild type nor po/f/- animals developed tumors. Our
novel mouse model introduces combinatorial polf] and poll knockouts into an
SKH1/hairless xpa-l- background. These mice are nucleotide excision repair (NER)deficient and develop tumors after only 8 weeks of UV irradiation. Using established
models of UV- and chemically-induced skin cancer, we will be able to identify any
previously unobserved effects of poll deficiency alone and in combination with polf]
deficiency during skin tumorigenesis. We will characterize the DNA damage and
apoptotic response of epidermal cells in order to identify changes in these characteristics
2

due to proposed tumor suppression by poll. Finally, we will directly test the somatic
mutation hypothesis of cancer by comparing in vitro mutagenesis results from Chapter 2
with in vivo carcinogenesis results.
Mutation and Cancer
Mutagenesis is a recognized cornerstone of every form of human cancer[1;28]
dating back to the discovery of aneuploidy in cancer cells[12]. According to the modern
somatic mutation hypothesis of cancer, a cell must undergo several independent genetic
and epigenetic events that together confer properties associated with the malignant
phenotype. These include acquisition of infinite lifespan, resistance to apoptotic signals,
growth factor independence, resistance to antigrowth signals, angiogenesis, and tissue
invasion[32]. Acknowledgment of the critical role of mutations in carcinogenesis opens
the possibility of chemoprevention using antimutator strategies. Although recent
advances have elucidated key details of the pathways underlying mutagenesis, there
exist critical gaps in our knowledge of the fundamental mechanisms by which DNA is
mutated during carcinogenesis. In this thesis, we will investigate how environmental
carcinogens permanently alter the sequence of DNA in order to cause cancer.
Translesion Synthesis in Eukaryotes
Recent evidence implicates DNA polymerase episilon (£) in leading strand DNA
replication, and delta (5) in lagging strand[65]. When these enzymes encounter adducts
that distort the helix, a variety of bypass mechanisms are initiated. This is particularly
true of adducts in the leading strand template. The signals that initiate these responses
are poorly understood at the present time, and constitute active areas of investigation in
many laboratories including our own. It has been shown using a plasmid containing a
site-specific acetylaminofluorene adduct that error-free damage avoidance accounts for
more than 92% of lesion bypass, and that mutagenic translesion synthesis accounts for
only 0.3% of bypass events[4]. It is clear from these studies that error-free homologous
3

recombination is the preferred method to resolve blocked replication forks in S.

cere visia e, and experts in the field generally agree that these mechanisms are
conserved in higher eukaryotic cells. Nevertheless, direct DNA synthesis past the lesion
clearly occurs in all cells, and is the source of virtually all mutations induced by genotoxic
carcinogens. This process is called translesion synthesis (TLS) and involves recruitment
of Y-family DNA polymerases. The signaling cascade that initiates TLS is poorly
understood. Data indicate that monoubiquitination of PCNA on K174 of each subunit is
an early event that appears to promote interaction with REV1 and polll in yeast. This is
also true of higher eukaryotic cells, but such cells have additional layers of complexity
because they have two additional homologues (POLl and POLK) that are not present in
yeast. The cell biology associated with these enzymes, which presumably act in concert
with REV1 and polf'l, is the subject of this thesis.

4

Figure 1.1. Model for trans lesion synthesis. DNA damage causes arrest of the
replication fork and recruitment of RAD6/RAD18 and REV1. Monoubiquitination of
peNA facilitates recruitment of pol'l, poll, or pOlK to synthesize 1-2 nt directly past the
lesion. Extension by

pol~

leaves a suitable primer template for continued replication by

polo or pol£.

5

Each of the V-family enzymes is characterized by an open active site that is
capable of accommodating damaged DNA, but the costs of this unique capacity are
fidelity and processivity[59]. REV1 is required for TLS in eukaryotes[30;4o], but appears to
primarily playa structural role in recruiting other V-family polymerases to actively bypass
the damage[54;s2]. Only 1-2 nt are inserted by poll1, I, or K before they dissociate from the
DNA, allowing extension by pOh~[37;55], another critical TLS polymerase[4o;51]. This
extended primer terminus is sufficient for continued replication by pol5 or £. Although in

vitro studies using purified enzymes have addressed the kinetics of bypassing specific
lesions by individual polymerases, we designed this project to fill critical gaps in our
knowledge of the cellular roles of V-family polymerases.
The most striking role for TLS in humans is in xeroderma pigmentosum variant
(XPV) syndrome. XP patients are extremely prone to UV-induced skin cancer because
cells from most patients are deficient in proteins of the nucleotide excision repair (NER)
pathway, which is responsible for recognizing and removing structurally diverse adducts
that distort the DNA helix. However, cells from a subset of XP patients were found to be
NER-proficient, despite the fact that the individuals displayed the classical XP
phenotype[49;73]. These patients were found to be deficient in DNA polymerase 11[35;44]
and theirs are the most hypermutable known human cells in response to UV, despite the
fact that NER actively repairs UV damage comparably to wild-type cells[77].

In vitro

studies revealed that POLI1 replicates TT cyclobutane pyrimidine dimers, the most
frequent lesions induced by UV, as faithfully as an undamaged TT template[36;43;44].
Hence, lack of POLI1 results in TLS past UV-induced lesions by more error-prone
polymerases. Recently developed knockout mouse models have been used to examine
the in vivo role of poll1 and poll in response to chronic UV exposure. polr( polt/+ mice
were extremely susceptible to UV-induced skin cancer and their cells displayed a similar
hypermutable phenotype to their human counterparts, validating the mouse model of
6

XPV[27;58]. Our group showed that fibroblasts from polr( pol1+ mice showed decreased
UV-induced mutation frequency; however, these mice developed tumors about twice as
fast as polr( polt l + mice[27]. Deficiency in poll was also required for metastases and
was associated with increased tumor burden[58]. These data suggest a role for poll as a
tumor suppressor that is separate from its mechanism as a mutagenic polymerase, since
deficiency in the enzyme decreased mutation frequency and yet increased tumor
development and tumor burden. We will investigate the tumor suppressor role of poll in
this project.

Recruitment of V-Family Polymerases
Previous reports showed that while POLry deficiency in human cells drastically
increased the UV-induced mutation frequency, no effect was seen on mutagenesis
induced by benzo[a]pyrene-7,8-diol-9,1 O-epoxide (BPDE)[78]. In contrast, recent studies
by our group have shown that BPDE-induced mutation frequency is decreased in POLry·l.
human and murine fibroblasts (see References). These results are consistent with
reports of error-prone bypass of BPDE damage using purified pOI'l[87;88;92]. Along with
the novel finding that pol'l acts in error-free bypass of UV damage and error-prone
bypass of bulky BPDE lesions in live mammalian cells, our results suggest that the
recruitment of Y -family polymerases to stalled replication fork is

not dependent upon the

lesion. Rather, we hypotheSize that pol'l is the primary TLS polymerase and is recruited
to stalled replication forks first, and in its absence poll or pOlK would be allowed greater
access to the lesion. We will examine this hypothesis in Chapter 2 using knockout
models of pol'l and poll in response to treatment with chemically distinct genotoxicants.

DNA Damage and Cell Cycle Checkpoints
Environmental carcinogens such as benzo[a]pyrene, aminofluorene, and
nitropyrene are metabolically activated and bind to DNA forming bulky, helix-distorting
lesions[6;7;22;63;72]. These adducts are recognized and removed by nucleotide excision
7

repair[17;18;47;48]. However, if these adducts remain in the DNA when the cell enters Sphase they pose a significant threat to genomic integrity: the DNA replication complex
cannot replicate past such adducts in the template. Although the proximal signals are
poorly understood at the present time, stalled replication forks activate cell cycle
checkpoints, presumably to allow removal of the adducts. Checkpoints are complex
signal transduction pathways that block cell cycle progression in response to DNA
damage[93]. These pathways exist for G 1, S, G 2 and M phases to manage potential DNA
damage throughout the cell cycle; the intra-S checkpoint is most relevant to this thesis.
The molecular mechanisms underlying the activation of this checkpoint are not well
understood. Available data indicate that stalled replication forks initiate the S-phase
checkpoint by recruitment of the protein kinase ATR, and to a lesser extent the related
protein ATM. ATR recruitment is dependent on a structural protein (ATR interacting
protein) and may be initiated by extensive regions of single stranded DNA coated by
RPA[95;96]. The downstream targets of phosphorylation by ATRlATM are myriad, and in
this context are thought to promote degradation of cofactors that are required for
progression through S-phase.
It is of interest that bulky adducts induced by BPDE elicit an S-phase checkpoint
in human lung carcinoma cells[31;79] that is dependent upon the Y-family polymerase

K.

A deficiency in this polymerase results in failure to recover from BPDE-induced S-phase
arrest and causes double strand breaks, likely due to collapse of stalled replication
forks[10]. This is the first direct evidence of cellular requirement for a translesion
synthesis polymerase for cell cycle regulation, and supports the hypothesis that such
polymerases are implicated in the activation of the intra-S-phase checkpoint. This
hypothesis is strengthened by a recent report that human cells with significantly reduced
expression of REV7 showed a decreased rate of S-phase progression after UV
irradiation[50]. REV? is the non-catalytic partner of REV3 in the B-family polymerase
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POLS, the first discovered TLS polymerase[56]. In Chapter 3, we propose to examine the
hypothesis that the tumor suppressor function of poll is due to a similar function of this
polymerase in activating cell cycle checkpoints.
miRNA and Cancer
miRNA are 20-22 base RNAs which negatively regulate gene expression by
destabilizing target mRNAs. Initial transcription of miRNA genes yields larger primary
miRNAs (pri-miRNAs) which are cropped by nuclear enzymes into -65nt hairpin-shaped
precursors (pre-miRNAs). Pre-miRNAs are exported into the cytoplasm, where further
processing yields a 22 nt duplex which complexes with the miRNA-induced silencing
complex (miRISC). This complex can target other transcripts for degradation through
perfect sequence complementarity in the 3' UTR of the target or, likely more common in
animals, repress translation of targeted transcripts through indirect complementaritye;14].
miRNA gene expression patterns are greatly altered in many cancers, and several
miRNAs are known to target oncogenes or tumor promoters (reviewed in [86]), making
them strong candidates for cancer studies. It has been shown by our collaborators that
the ubiquitous carcinogen BPDE alters miRNA gene expression profiles in small airway
epithelial cells (unpublished observations). We hypothesize that poll status will alter
miRNA gene expression changes induced by other carcinogens, including UV, and that
these changes will provide insight as to the pathways effected by poll proficiency.
Skin Cancer as a Tumorigenesis Model
More than one million new cases of non melanoma skin cancer (NMSC) will be
diagnosed in the U.S. in 2007, making it the most commonly diagnosed cancer in the
country (American Cancer Society 2007 Facts and Figures). Ultraviolet radiation is the
most ubiquitous carcinogen in the environment and is the primary etiological agent
causing NMSC. Carcinogenesis from environmental UV exposure can be attributed to
radiation ranging from 280 - 320 nm in wavelength (UVB), which generates
9

photoproducts in DNA capable of causing mutations. Short-wave UV (UVC) ranges from
100 - 280 nm and is also highly carcinogenic, but is filtered out completely by
atmospheric ozone and is thus not environmentally relevant. UVA is characterized by
wavelengths between 320 - 400 nm and is only carcinogenic at much higher doses in
mice compared to UVB due to absorption by cellular chromophores other than DNA and
principle production of reactive oxygen species[9;52]. Ultraviolet radiation produces
measurable effects in human and mouse skin. Trp53 is frequently mutated in UVinduced mouse and human skin cancers[13;53], and this mutated tumor suppressor
causes formation of precancerous clones in irradiated skin[8;38]. UV also induces a well
characterized apoptotic sunburn response which appears to require wild type trp53.
Sunburn cells are characterized by pycnotic nuclei and intensely eosinophilic cytoplasm,
as well as DNA strand breaks[94]. We hypothesize that poll promotes p53 accumulation,
cell cycle arrest, and apoptosis in its role as a tumor suppressor.
Xeroderma pigmentosum (XP) has been described as a syndrome characterized
by extreme predisposition to UV-induced skin cancer. The majority of patients have
dysfunctional NER, resulting in faulty recognition and repair of helix distorting lesions
including 6-4 photoproducts and cyclobutane pyrimidine dimers (CPO) induced by UV.
Patients from XP complementation group A display the most severe phenotype,
including extreme photosensitivity and neurological defects, and typically die of
metastatic skin cancer early in life. Hairless mice that are homozygous xpa-I-, developed
by Harry van Steeg, display a similar phenotype and are extremely susceptible to UV
carcinogenesisC 9] with a tumor latency of -10 weeks as compared to -1 year with Balb/c
mice ([27] and unpublished observations). The van Steeg mice represent an excellent
and well studied skin cancer model[19;21;26;66;74;75] and will be used in this thesis.
Benzo[a]pyrene (B[a]P) is also a well studied skin carcinogen. It is clear that
benzo[a]pyrene-7,8-diol-9,10-epoxide (BPDE), a metabolic derivative of B[a]P, is the
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ultimate carcinogen[11;71]. BPDE formation proceeds through the action of CYP450,
microsomal epoxide hydratase, and repeated CYP450 oxidation (reviewed in[62]).
Carcinogenic activity of B[a]P is primarily due to in vivo binding of the ultimate
carcinogen to DNA to form bulky adducts[71]. As analyzed by 32p-postlabeling, stable
2
BPDE-N -dG adducts constitute over 98% of adducts formed in mouse skin treated with
anti-BPDEC 6]. These adducts are normally recognized and repaired by enzymes in the
NER pathway, and the NER-deficient mice we propose to use have been shown to
accumulate more BPDE:DNA adducts than wild-type mice after B[a]P treatment[20].
These mice are also more sensitive to B[a]P-induced lung carcinogenesis[33], and
represent an excellent model for chemical carcinogenesis.
Acetylaminofluorene (AAF) is a well characterized model mutagen and liver,
intestine, and urinary bladder carcinogen. AAF is subject to numerous metabolic
activities in vivo that can result in formation of electrophilic intermediates capable of
binding to DNA. N- and O-acetylation, hydroxylation, and sulfation all may lead to
activation of the compound through many possible pathways[5]. Three major adducts
are formed by AAF in vitro and in vivo and serve as NER substrates. AAF-C8-dG and
AF-C8-dG form at differing ratios depending on cell type and activity of microsomal
deacetylase[63]. AF-N2-dG is formed as a minor but persistent adduct in vivo[Bo] and is
significantly less mutagenic than C8-dG adducts[84]. In mouse epidermal cells treated
with the active metabolite N-acetoxy-2-acetylaminofluorene (AAAF), AF-C8-dG adducts
make up over 90% of DNA adducts formed[63]

Significance
Our studies support a role for mouse poll in mutagenic translesion synthesis and
in tumor suppression after UV exposure. In addition, limited available evidence indicates
there may be differences in Y-family polymerase activities in response to UV and
chemical damage. These areas represent critical gaps in our knowledge of mammalian
11

mutagenesis. We hypothesize that DNA polymerase I acts as a mutagenic polymerase
in translesion synthesis and as a tumor suppressor through a separate mechanism. We
propose to investigate the cellular roles of Y-family polymerases in order to further
understanding of the mechanism of carcinogenesis by environmental agents with the
ultimate aim of preventing cancer caused by these agents.
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CHAPTER 2

EVALUATE THE MUTAGENIC PROPERTIES OF CHEMICAL CARCINOGENS IN
MAMMALIAN FIBROBLASTS DEFICIENT FOR Y-FAMILY POLYMERASES
INTRODUCTION
In this Chapter we will compare the cytotoxic and mutagenic properties of BPDE
and AAF. BPDE is the ultimate genotoxicant metabolized from the ubiquitous
carcinogen benzo[a]pyrene and primarily forms N2-dG adducts[15;69]. This carcinogen
will be used in Chapter 4 for in vivo tumorigenesis studies. AAAF is the active
metabolite of AAF and primarily adducts C8 of deoxyguanosine[57]. This Chapter will
allow us to examine the hypothesis that structurally different chemical adducts have
varying mutagenic activity when bypassed by V-family polymerases. We will also
directly test the somatic mutation hypothesis of cancer by correlating in vitro
mutagenesis data with in vivo tumorigenesis data collected in Chapter 4.

13

MATERIALS AND METHODS

Cell lines to be used
We used established NF1604, XP4BE, and XP115LO human cell lines as well as
primary fibroblasts from knockout mice. NF1604 cells were isolated from normal fetal
lung tissue, and XP4BE and XP115LO cells are from XP variant patients. All lines are
stably transfected with a plasmid expressing human telomerase reverse transcriptase.
This gives them an infinite lifespan, but they are otherwise normal[60]. polfJ knockout
mice were recently generated by our collaborators in a C57BI/6 hybrid background[42].
To generate polfJ-1-po/f/- double knockouts, these animals were bred with 129/0la mice,
which have been shown to carry a nonsense mutation in poll resulting in a protein
truncated at Ser-27[45]. Primary fibroblasts have been isolated from these mice and
used for mutagenesis studies in our laboratory[27], and these cells were used in this
Chapter. Mouse fibroblasts were grown in monolayer cultures using a-MEM
supplemented with non-essential amino acids, penicillin-streptomycin and 10% fetal
bovine serum. They were maintained in exponential growth. We routinely grow primary
murine cells in a 3% 02/5% C0 2/92% N2 atmosphere[61].
hprt mutagenesis
For genotoxicant treatment, cells were plated at 1 x 104 cm- 2. The culture media
was removed and cells were washed twice with sterile phosphate-buffered saline (PBS,
pH 7.4). Serum-free media was added to the cells along with each chemical carcinogen
for a period of one hour. Doses of 0 - 250 nM BPDE and 0 - 2.0 IJM AAF were used for
cytotoxicity studies. We used the dose giving -37% survival for mutagenesis studies.
After one hour of treatment, the culture media was aspirated followed by two washes in
PBS. For cytotoxicity, cells were trypsinized and counted, then replated at cloning
density (the exact number depends on the expected survival). After two weeks, plates
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were stained with 1% crystal violet and counted. For mutagenesis, cells were
maintained in exponential growth for eight days after treatment, after which we
trypsinized, counted, and selected 1 X 106 cells with 40 IJM 6-thioguanine at a density of
3000 cm-2. After 2 weeks of selection, we isolated individual TG r clones, trypsinized,

and resuspended them in RNase-free PBS. The technique for amplifying the hprt gene
was performed as described[83] with modifications routine in our laboratory[23]. Briefly,
r

TG colonies were pelleted at 4'C and the PBS removed. The cells were directly lysed
and cDNA generated using a cDNA cocktail. After incubation at 37'C for 1 h
amplification was performed using a Taq polymerase cocktail and two outer primers. The
5' primer is from position -47 to -28 relative to the start codon (GGC TTC CTC CTC AGA
GGG CT). The 3' primer is from position 790 to 771 (ACA TCA ACA GGA CTC CTC GT).
Reamplification using an inner primer set (5', from -27 to -8, TTT TGC CGC GAG CCG
ACC GG and 3', from 770 to 751, ATT TGC AGA TTC AAC TTG CG) will follow. The
PCR products were sequenced with each of the inner primers using an ABI 370
automated DNA sequencer and dRhodamine dye terminator chemistry.

15

RESULTS

BPDE in Human Fibroblasts
We treated POLr( XP115LO and wild type NF1604 human fibroblasts with 150
or 200 nM BPDE and measured clonogenic survival and mutagenesis. These cells are
isolated from an XP variant patient (XP115Lo) and normal fetal lung (NF1604) and are
stably transfected with a plasmid expressing human telomerase reverse transcriptase.
This gives them infinite lifespan, but they are otherwise normal[46;76]. After treatment and
eight days of expression, cells were selected with 6-thioguanine (TG). Table 1 shows
that XP variant fibroblasts are moderately sensitive to killing by BPDE, which is similar to
the phenotype displayed by XP variant cells in response to UV[49]. However, unlike XPV
cells after UV irradiation, XP115LO fibroblasts showed decreased mutation frequencies
when compared to wild type NF1604 fibroblasts (Table 1). This novel result has been
reproduced over three experiments using these cells and is consistent with published
reports of in vitro error-prone TLS by purified human POLIl past BPDE-N 2-dG DNA
adducts[87;88;92]. Our results indicating POLIl in error-prone TLS of BPDE lesions
contrasts with the known role of POLIl in error-free TLS past UV-induced lesions. Our
conclusion that POLIl acts in error-prone bypass of BPDE lesions is also in sharp
contrast with a report that POLIl is unresponsive to BPDE lesions in human POLr]"'"
XP4BE cells[77]. We amplified and sequenced the HPRT gene from mutant colonies and
found very little difference in the mutation spectrum, e.g. the types of mutations induced,
of wild type NF1604 and POLl/" XP115LO fibroblasts (Table 2). The similarity in BPDEinduced base substitution indicates that the enzyme acting to bypass the BPDE lesion in
the absence of POLIl has a similar mutation spectrum for this adduct.

16

BPDE in Murine Fibroblasts

To extend the results we obtained from studies of human cells, we performed
similar experiments with primary murine fibroblasts deficient for pol'l, poll, or both. We
first compared the sensitivity to BPDE of the cells using in situ cytotoxicity tests. For this
method, cells were plated at cloning density and treated with varying doses of BPDE.
Figure 2.1 displays the results of one experiment which show no apparent differences in
the cytotoxicity of BPDE among the four cell lines, although significant sensitivity of polr,I·

poll-!- double knockout cells may be shown after experimental replication. The dose

resulting in 37% survival (D37) for each cell line was -100 nM. It is known from
unpublished observations that mouse primary fibroblasts are more sensitive to
genotoxicant treatments at low densities. It is for this reason that further cytotoxicity
studies are performed by treating cells at 1 x 104 cells/cm 2 and immediately replating at
cloning density. This method of replating cytotoxicity accurately reflects the survival of
cells treated at equal density for mutagenesis. Figure 2.2 shows the results of one or
two replating cytotoxicity studies using 150 nM BPDE, the known D37 of wild-type
primary murine fibroblasts at replating density. As in Figure 2.1, there are no obvious
differences in sensitivity to BPDE treatment with the possible exception of the double
knockout cells. Significantly, we used heterozygous polrtl - poltl + cells for experiments
shown in Figures 2.2 and 2.3. These cells were provided by a collaborator as
homozygous polf] knockouts and were genotyped for confirmation of that only after
these studies were completed. We have since verified by peR all genotypes indicated
in this thesis. Strikingly, haploinsufficiency for polf] in these cells was sufficient to
markedly reduce the mutation frequency induced by 150 nM BPDE as shown in Figure

2.3. These results support our studies of human cells indicating POL'l in error-prone
bypass of BPDE DNA adducts in contrast to its role in error-free bypass of UV damage.
Similarly, polf]+I+ poll-!- fibroblasts showed drastically reduced mutation frequencies after
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BPDE treatment, and polr( pol,-'- cells exhibited a 98% reduction in hprt mutations
induced by 150 nM BPDE These results reflect the findings of in vitro studies which
have characterized the error-prone bypass of BPDE-N 2-dG DNA adducts, the major
adduct induced by this carcinogen, by purified POLr) and POLI[67]. We hypothesize that
the low mutation frequency of poll{ po,,-!- double knockout murine cells is due to errorfree lesion bypass by POlK, which has also been characterized in vitro[90;91].
AAAF in Murine Fibroblasts

We examined the cytotoxic effects of N-acetoxy-2-acetylaminofluorene (AAAF)
using replating cytotoxicity assays. This well characterized mutagen is a major
metabolite of acetylaminofluorene, a carcinogen present in diesel exhaust, and
predominantly forms AF-C8-dG adducts[63;64]. This lesion is structurally distinct from the
N2-dG adduct which predominates after BPDE treatment, and the differences in
cytotoxicity of the two chemicals are readily apparent in Figure 2.4. As compared to the
very similar sensitivities of these cells to treatment with BPDE, poln and/or poll deficient
murine fibroblasts appear to be more sensitive to killing by AAAF. The D37 calculated
from these studies varies from 0.83 IJM for wild type cells to 0.16 IJM AAAF for poln-' polfl - double knockout cells_ This pattern of increased sensitivity is very similar to that
characterized by our group after UV treatment of these cells[27], and supports a role for
these enzymes in prevention of replication fork collapse and double strand break
cytotoxicity. We hypothesize based on in vitro studies of purified yeast polr)[85] and
human POLI[89] that polr) acts in error-free bypass of AAAF-induced DNA damage, while
poll participates in error-prone TLS of the lesion. We will investigate this lesion-specific
fidelity of cellular polr) and poll further in Chapter 4.
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Experiment

1

2

3

BPDE Dose (nM)

150

150

200

1604

73

62

33

XP115Lo

53

55

21

263

208

483

53

85

104

Percent Survival

Induced Mutants 1106 1604
Clonable Cells

XP115Lo

Table 2.1. Cytotoxicity and mutagenesis of BPDE in human cells. Transformed human
fibroblasts from normal (1604) or XP variant (XP115Lo) patients were treated with 150 or
200 nM BPDE. XP115Lo cells appear to be slightly more sensitive to the treatment and
are hypomutable.
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1604

XPV

8.3

8.7

G>A 8.3

8.7

Transitions

91.7

91.3

G>T 58.3

69.6

G>C 8.3

17.4

A>T 25.0

4.3

Transversions

Table 2.2. BPDE-induced HPRT point mutations in human fibroblasts. Thioguanineresistant clones were isolated after BPDE treatment. HPRTmRNA was reverse
transcribed and amplified by peR for sequencing. Numbers represent percentage of
total point mutations.
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Figure 2.1. Survival of murine fibroblasts after BPDE. Primary dermal fibroblasts
isolated from mice of the indicated genotypes were treated with BPDE at cloning density
and refed after one week. After two weeks, colonies were stained with crystal violet and
counted to assay survival. It should be noted that these cells are more sensitive to
chemical genotoxicants when treated at low density.
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Figure 2.2. Suvival of murine fibroblasts after 150 nM BPDE. Primary dermal fibroblasts
isolated from mice of the indicated genotypes were treated with BPDE at 10-4 cm-2 for
one hour and immediately replated at cloning density. Note that a polf] heterozygote
was used.
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Figure 2.4. Cytotoxicity of AAAF in murine fibroblasts. Primary dermal fibroblasts
isolated from mice of the indicated genotypes were treated with AAAF at 104 cm- 2 for
one hour and immediately replated at cloning density. Cells were refed after one week
and stained with crystal violet after two weeks.
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CONCLUSIONS AND FUTURE DIRECTIONS

We conclude from these initial data that neither pair) nor poll is likely to contribute
to cellular survival after BPDE treatment, although loss of pair) appears to make cells
more sensitive to AAAF. Strikingly, we found that both paIr] and poll deficiency caused
reduced mutation frequency after BPDE treatment in our primary dermal fibroblasts.
This effect was also seen in human cells deficient for paIr]. This supports a role for both
enzymes in error-prone, mutagenic bypass of BPDE:DNA lesions. This is confirmation
of results using purified pair) and poll, but in contrast to published reports that pair]
deficiency in human cells causes no change on BPDE-induced mutation frequency[77].
AAAF causes structurally distinct DNA lesions and appears to be more cytotoxic
to murine cells deficient for paIr]. poll status did not appear to modulate AAAF
sensitivity. These results are similar to the effect of deficiency for these enzymes on UV
sensitivity[27], and we will investigate mutagenesis by this carcinogen at the hprt locus as
we have for BPDE. We hypothesize based on in vitro experiments[85;89] that polr)
participates in error-free bypass of AAAF damage and that poll is active in error-prone
bypass of these lesions, again similar to the known roles of these enzymes in UV
damage bypass[27].
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CHAPTER 3

INVESTIGATE THE TUMOR SUPPRESSOR ROLE OF MURINE POL IOTA
INTRODUCTION
We have shown that poll deficiency in a polr( background causes decreased
UV-induced mutation frequency and decreased UV-induced tumor latency[27], indicating
a possible tumor suppressor role for the enzyme. It has been shown that poIK-1- mouse
fibroblasts arrest in S-phase and display increased checkpoint signaling after treatment
with BPDE and that recovery from this checkpoint is dependent upon pOlK. We propose
to investigate the tumor suppressor role of poll in this Chapter, specifically focusing on
cell cycle checkpoint signaling. We will also investigate differential miRNA and global
gene expression responses to UV damage to determine the regulation of other genes
and pathways by poll.
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MATERIALS AND METHODS

Irradiation protocol

Cells were plated at cloning density (the exact number depends upon the
expected survival) or 1 x 104 cm· 2 and allowed to attach overnight. The culture medium
was then be aspirated and cells will be exposed to 1 - 20 J/m·2 UVC. Culture medium
was immediately replaced and cells were refed at one week and stained for counting
and cytotoxicity determination at two weeks or harvested at various time points for
analyses detailed below.
Global gene expression

In order to identify potential effects of poll expression on a larger scale, we
examined the effects on global gene expression due to loss of pol'1, poli, or both in
primary murine fibroblasts. This experiment was designed to discover the effect of poll
deficiency on the expression of genes in known tumor suppressor or promoter pathways.
Cells were irradiated with 20 Jcm·2 at 1 x 104 cm· 2 and total RNA was extracted using the
Qiagen miRNeasy kit. After amplification, resultant cDNA was transcribed using the
GeneChip@ IVT Labeling Kit for hybridization on Affymetrix MOE 430_2.0 arrays using a
GeneChip@ Scanner 3000 7G. Statistical analysis (ANOVA) of the microarray data was
performed to evaluate significant changes between the groups with a q-Value <0.05
using FDR (False Discovery Rate) multiple testing correction and Partek 6.1 software.
We examined expression patterns associated with UV treatment, as well as differences
in UV response between all cell lines. We randomly verified results using quantitative
real-time PCR and Western Blots for affected proteins.
miRNA microarrays
To investigate the effect of poll deficiency on cancer-regulating miRNA
expression, we analyzed global miRNA gene expression using a microarray-based
27

assay (LC Sciences). Total RNA samples isolated before and after UV treatment were
enriched for miRNA, labeled with Cy3 or Cy5, and hybridized to a dual-color microarray
chip. For this technique, the relative abundance of each miRNA in each sample was
analyzed by the proportion of Cy3/Cy5 fluorescence at each probe site on the chip.
Each chip contains six redundant probes for each of the known 568 mature mouse
miRNAs. After background subtraction and data normalization, statistical correlation
between the three chips representing independent biological replicates identified any
miRNA genes altered between groups. As above, we analyzed data for UV-responsive
miRNA and differences in UV response between cell lines. Results were randomly
validated using Northern Slots and RT-PCR.
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RESULTS

To determine the potential mechanism by which poll acts as a tumor suppressor
in mammalian cells, we examined UV-induced changes in global gene expression in

polr( poltl+ and polr( poll-!- primary murine fibroblasts. Our group previously showed
that polr( poll-!- fibroblasts get fewer mutations after UV exposure, but mice with this
genotype have a decreased UV-induced tumor latency compared to the XPV model

polr( poltl+ mice[27]. To examine the effect of poll deficiency on global gene expression,
we plated cells at 1 x 104 cm· 2 24 hr before treatment with 4 Jm·2 UVC. mRNA was
isolated 24 hr after treatment, reverse transcribed into cDNA and amplified for global
gene expression using Affymetrix Mouse Genome 430 2.0 GeneChip® arrays. For data
analysis, we used a 2-way ANOVA incorporating cell line and treatment as well as their
interaction as factors. The resulting p-Values were false discovery rate (FOR) corrected
and cut off at a corresponding q-value of 0.05. Table 3 shows the 19 genes whose
expression was modulated in different ways by treatment with UV between polr( poltl+
and polr( po/f/- cells. For example, protein tyrosine phosphatase receptor type V (ptprv)
was the gene that showed the most statistically significant differential expression in the
cell lines after UV exposure. In polr( poltl+ cells, UV induced a 1.56-fold upregulation of
ptprv, while a 5.67-fold UV-induced upregulation was observed in polr(" po/f/- cells. This
gene has only recently been characterized[41], but has already been linked to p53
signaling, cell cycle checkpoints, and tumor suppression[24;25]. ADAMB (A Disintegrin
And Metalloprotease 8) has been shown to be a possible diagnostic marker for lung
cancer and renal cell carcinoma in humans[34;68] and is negatively correlated with
prognosis in prostate, renal cell, and brain cancers[29;81]. Also relevant to this project is

cdc20, which promotes progression through and exit from M phase and is often
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overexpressed in malignancies[2;39]. These genes will provide an important basis for the
investigation of the tumor suppressor role of poll.
We also examined the effects of UV treatment on miRNA expression in these
cells. Total RNA isolated after the treatment described above was enriched for miRNA
and labeled with Cy3 or Cy5. Samples were hybridized in oppositely labeled pairs to two
identical dual-color microarray chips containing probes for the 568 known mature
miRNAs from the Sanger Database v1 0.0. Figure 3.1 shows results after background
subtraction and data normalization. Expression of the miRNA listed was modulated after
UV treatment. To our knowledge, this is the first evidence of altered miRNA expression
after UV radiation in mammals. Using bioinformatics tools including the Sanger miRNA
database for target mRNA prediction, we will be able to correlate miRNA expression
data from all four cell lines to discover commonly affected tumor suppressor and
promoter pathways altered by polt deficiency.
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Name

PTPRV
ADAM8

Description

protein tyrosine phosphatase,
receptor type, V (pseudoqene)
ADAM metaliopeptidase domain 8

phorbol-12-myristate-13-acetateinduced protein 1
KIF23
kinesin family member 23
solute carrier family 9
SLC9A3R (sodium/hydrogen exchanger),
1
member 3 regulator 1
ODZ3
odz, odd Ozlten-m homolog 3
(Drosophila)
PRKG1
protein kinase, cGMP-dependent,
type I
C80RF4 chromosome 8 open reading frame
GST01
glutathione S-transferase omega 1
CDC20
cell division cycle 20 homolog (S.
cerevisiae)
PC
pyruvate carboxylase
diacylglycerol kinase, alpha 80kDa
DGKA
RAD54-like (S. cerevisiae)
RAD54L
solute carrier family 9
SLC9A3R (sodium/hydrogen exchanger),
member 3 regulator 2
2
crystallin, alpha B
CRYAB
EFS
embryonal Fyn-associated
PAIP1
poly(A) binding protein interacting
protein 1
KCNIP1
Kv channel interactinq protein 1
MAN1A1 mannosidase, alpha, class 1A,
member 1
PMAIP1

pvalue
0.010

Fold Change
(polTJ -/- poll +1+)
1.56

Fold Change
(polTJ -/- poll-I-)
5.674

0.016
0.018

-1.01
2.21

1.557
24.246

0.019
0.022

1.98
-1.18

1.349
1.229

0.023

-1.11

-3.631

0.026

-2.34

-4.339

0.037
0.041
0.041

2.69
1.33
1.78

1.362
1.091
1.422

0.042
0.042
0.042
0.044

1.28
1.52
1.63
-1.03

1.697
2.467
1.308
1.433

0.045
0.045
0.048

2.80
2.83
1.30

1.678
5.238
-1.255

0.048
0.050

-1.30
1.12

-3.485
1.398

Table 3.1. Differentially regulated, UV-responsive transcripts in primary murine
fibroblasts. Dermal fibroblasts were treated with 4 Jm-2 and total RNA was isolated after
24 hr. Affymetrix Mouse Genome 430 2.0 GeneChip arrays were used to quantify
mRNA levels. UV-responsive mRNAs were identified using 2-way ANOVA incorporating
cell genotype and treatment, as well as their interaction, as factors. The 19 genes
shown here were differentially regulated by UV treatment between cells of the two
genotypes.
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Figure 3.1. UV-responsive miRNA. Primary dermal fibroblasts were treated with 4 Jm·2
and total RNA was collected after 24 hr. After enrichment for small RNA, samples were
labeled with either Cy3 or Cy5 and hybridized in oppositely labeled pairs to two identical
dual-color microarray chips containing probes for mature murine miRNA from the Sanger
Database v10 .0. Two-way ANOVA was used to identify miRNAs with modulated
expression after UV.
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CONCLUSIONS AND FUTURE DIRECTIONS

We have shown that UV radiation causes modulated mRNA and miRNA
expression in our model system, primary dermal fibroblasts from mice. This is the first
report of UV-responsive miRNA in mammalian cells. We have also shown that poll
deficiency modulates both global gene and miRNA expression. We defined 19 genes
that displayed differential UV modulation between polr{'- polt'+ and polr( pol{'- cells. We
also defined mutually exclusive lists of nine and 11 miRNAs with modulated expression
in polr( poll+i+ and polr( poll-!- cells, respectively. The readily apparent differences in
gene expression in these cells supports our hypothesis that poll could act as a tumor
suppressor by modulating gene expression. To further investigate this hypothesis we
will validate our initial results using qRT-PCR and western blotting for target protein
levels.
In order to investigate cell cycle checkpoint activation after UV and the effects of
poll deficiency, we will treat cells derived from mice deficient for polrl, poll, or both with
UV and utilize FACS analysis of cell cycle progression. We will also examine levels of
checkpoint proteins and their phosphorylated epitopes via westen blot to detect
activation of G1/S and G2/M checkpoints after UV treatment. These will include chk1
and chk2 along with phosphorylated epitopes chk1-phopho-Ser345 and chk2-phosphoThr68. We hypothesize that poll deficiency will promote cell cycle progression after UV
damage, thereby promoting increased mutagenesis and/or chromosomal instability and
promoting transformation of

pOI(I-

cells.
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CHAPTER 4

CHARACTERIZE THE EFFECT OF POL IOTA DEFICIENCY ON IN VIVO SKIN
TUMORIGENESIS USING A NOVEL MOUSE MODEL
INTRODUCTION
In this Chapter we propose to generate a novel mouse model for TLS-mediated
UV- and 8[a]P-induced skin cancer. This model is ideally suited for the hypothesis that
poll acts as a tumor suppressor in vivo as we know that 100% of control SKH 1/hairless

xpa-I - mice will develop tumors after UV and chemical treatment. We hypothesize that
deficiency in poll will result in decreased tumor latency after UV irradiation and 8[a]P
carcinogenesis. Combined sunburn cell quantification and TUNEL assay will allow us to
compare apoptosis in the epidermis of UV-irradiated mice. We hypothesize that poll
deficiency will result in decreased levels of p53 and p21 activation and consequently
decreased apoptosis, providing the basis for a tumor suppressor mechanism. We will
also compare in vitro mutagenesis data using 8PDE from Chapter 2 with data from the
8[a]P tumorigenesis experiment outlined in this Chapter. This will allow us to directly
test the somatic mutation hypothesis of cancer and investigate chemical-induced tumor
suppression by poll.
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MATERIALS AND METHODS

Mouse Model

Previous studies used a combinatorial pol!} and poll knockout mouse model in a
mixed 129/0la X C57BI/6 background. This model is not ideal for UV carcinogenesis
studies for two reasons. First, the mice must be shaved twice weekly for UV treatment.
Second, neither wild type nor pol!}+I+ poll';' mice develop tumors after 20 weeks of UV
treatment. For this reason, we are backcrossing these mice into an SKH1/hairiess xpa·/·
background. These mice were developed by Harry van Steeg and develop tumors after
as few as 6 weeks of UV with an average latency of as little as 10 weeksC 9]. The UVinduced cancer-prone phenotype of these mice will be an ideal background for
elucidating the difference in skin cancer susceptibility between wild type and pol!}+1+ poll-!mice, which is critical for our hypothesis that poll acts as a tumor suppressor in vivo. To
breed the mice, we back crossed C57BI/6 pol!}·/l42] and 129X1/SvJ (JAX), which are
naturally pol{I.[45], with SKH1/hairiess xpa·/- mice. We monitored the hairless (hi) locus
via screening for hairless pups at 4 weeks of age. We monitored xpaf1], pol!}t 2], and

pollt5] using published PCR-based screens and genomic DNA from tail snips. All mice
from generation F2 will be screened for hrl- xpa·l. status as well as heterozygosity for the
polymerase gene (pol!} or poll) and backcrossed into the SKHlIxpa-l. background for at
least six generations[70]. Double knockout mice will be bred by crossing homozygous F7

pol!}-I. pOll+l+ and pOI!}+I+ po/f/. mice to generate

h(/-

xpa·l. pOI!}+I- POII+I. animals. Doubly

heterozygous littermates will be mated to obtain homozygous knockouts at all four loci.
We have F2 pol!} mice and F2 poll mice in hand and expect to complete back crosses by
fall 2008.
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UV Irradiation protocol

A control group of 40 SKH1/hairiess xpa-l- mice were segregated according to
gender to prevent breeding over the course of the experiment and were housed in
groups of five. The UV-8 irradiation source is a bank of seven fluorescent FS40 T12
UV-8 sources (Westinghouse) that is placed -40 cm directly above the cages. (Pictures
of the UV bed are included in Section F, Vertebrate Animals.) These lamps have a
spectrum of 250-400 nm, peaking at -310 nm. The lamps were shielded with Kodacel,
which removes any short wave UV below 280 nm. The fluence wass determined at 313
nm using an International Light Radiometer with UV8-1 filter. The dorsal dose to the
mice was 200 J/m 2 per week, delivered in three exposures per week. This dose has
been determined as the lowest exposure level causing mild erythema (the minimal
erythema dose, MED) in our laboratory (unpublished observations). However, if the
mice develop erythema, the UV fluence to all groups will be reduced. After 4, 6, 8, or 10
weeks of such exposure, the UV irradiation was discontinued. The mice were examined
weekly for tumor development and tumors were confirmed by two observations in which
the volume of the tumor had increased. The mice were sacrificed if a tumor reached
10% of the animal's body mass. All mice were sacrificed 20 weeks after UV treatment
initiation.
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RESULTS

To determine the total UV dose necessary to ensure 100% of treated mice get
tumors, we divided 20 male and 20 female SKH1/hairiess xpa-l- mice into four groups.
Each group had five males and five females and was housed in groups of five
segregated by sex. We irradiated the mice with a dorsal dose of 66 Jm,2 UVB three
times weekly. Group one was irradiated for four weeks (total dose -800 Jm'2), group
two for six weeks (total dose -1,200 Jm'2), group three for 8 weeks (total dose -1,600
Jm'2), and group four for 10 weeks (total dose -2,000 Jm'2). One hundred percent of
group three mice developed tumors with an average latency of -12 weeks (Figure 4.1).
Accordingly, we decided to use the 1,600 Jm,2 cumulative dose over six weeks of UV
treatment for further experiments.
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Figure 4.1. Tumor latency of SKH1/hairiess xpa-I - mice. Four groups of ten mice each
were treated with 200 Jm-2 for the time periods indicated. Tumor growth was monitored
weekly and mice were killed 20 weeks after treatment initiation.
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Conclusions and Future Directions

We have shown that SKH1/hairiess xpa-I - mice are an excellent model for skin
cancer susceptibility due to the short latency of UV-induced cancers and the likelihood of
100% of the mice developing cancer. We are currently back-crossing these mice with

po/r( and po/f/- animals in order to examine the effects of deficiency for these genes on
skin cancer risk. Using this mouse model, we will be able to identify any effects on UVinduced skin cancer susceptibility due to poll deficiency alone, directly addressing our
hypothesis. This has not been possible in previous studies in which neither pol/- nor
wild-type mice developed cancer due to the NER-proficient wild type background of the
animals. In addition to UV carcinogenesis, we will examine carcinogenesis by topical
application of benzo[a]pyrene (B[a]P). This carcinogen forms bulky DNA adducts which
our results show are bypassed in an error-prone way by both pol" and poll. We
therefore hypothesize that mice deficient for these genes will have decreased incidence
of B[a]P-induced skin cancer.
In addition, we will examine the affects of acute UV and B[a]P exposure on the
skin of these mice through histological analysis and immunohistochemical staining. By
analyzing appearance of apoptotic and p53-positive cells, in addition to using the TUNEL
assay, we will quantify cellular death in response to carcinogen treatment. We
hypothesize that polt-deficient mice will display lower levels of cell death after UV,
measured partially by the appearance of apoptotic "sunburn cells," in correlation with
their proposed increased cancer risk.
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APPENDIX

List of Abbreviations
7-AAD

7-aminoactinomycin D

AAAF

N-acetoxy-2-acetylaminofluorene

ATM

Ataxia telangiectasia mutated

ATR

Ataxia telangiectasia related

B[a]P

Benzo[a ]pyrene

BPDE

7R,8S-dihydroxy-9S,1 OR-epoxy-7 ,8,9,1 O-tetrahydrobenzo[a]pyrene

BrdU

Bromodeoxyuridine

CPD

Cyclobutane pyrimidine dimer

DMEM

Dulbecco's modified Eagle's medium

DNA

Deoxyribonucleic acid

FACS

Fluorescence activated cell sorting

FBS

Fetal bovine serum

HPRT

Hypoxanthine phosphoribosyltransferase

IVT

In vitro transcription

miRNA

Micro-ribonucleic acid

mRNA

Messenger ribonucleic acid

NER

Nucleotide excision repair

NMSC

Non-melanoma skin cancer

NOP

1-nitrosopyrene

nt

nucleotide

PBS

Phosphate-buffered saline

PCNA

Proliferating cell nuclear antigen

pol

Polymerase
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RAD

Radiation sensitive

REV

Reversionless

RPA

Replication protein A

TG

6- Thioguanine

TLS

Translesion synthesis

Trp53

Transformation related protein 53

TUNEL

Terminal deoxynucleotidyl transferase dUTP nick end labeling

UV

Ultraviolet

XP

Xeroderma Pigmentosum
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Resources for Academic Achievement, Karen Seng

Tutor

University of Louisville
Louisville, KY
Dept of Pharmacology, W. Glenn McGregor, M.D.

2005

Undergraduate
Research
Assistant

MEMBERSHIPS in PROFESSIONAL and SCIENTIFIC SOCIETIES

Organization

Year

Society of Undergraduate Chemistry Students, University of Louisville
Vice President

2004 - 2006
2005 - 2006

Environmental Mutagen Society

2007 - Present

Ohio Valley Society of Toxicology

2007 - Present

American Association for Cancer Research

2008 - Present
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HONORS

Title of award, sponsor

Year

Dean's List, Centre College

2002 - 2003

Dean's List, University of Louisville

2003 - 2006

Cancer Education Program Fellowship, University of Louisville

2005

First Place Poster, Research!Louisvilie

2007

Travel Award, Environmental Mutagen Society

2007

Travel Award, University of Louisville School of Medicine

2007

Travel Award, University of Louisville Graduate Student Council

2007

PROFESSIONAL ACTIVITIES
SERVICE:
University of Louisville

Chair Search Committee, Dept of Biochemisty & Molecular Biology
MENTORING:
University of Louisville
Undergraduates

Brian Sils
Robert Skaggs
Anthony Smith
Christopher Belcher
Caleb Greenwell
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2007 - Present

PRESENTATIONS:

Local I Regional
2005

Poster Presenter, Research Louisville, UofL
Chronic Inflammation Does Not Alter Patterns of Gene
Expression in CarCinogen-Initiated Lung Cancer

2006

Poster Presenter, Posters-at-the-Capitol, Frankfort, KY
Chronic Inflammation Does Not Alter Patterns of Gene
Expression in Carcinogen-Initiated Lung Cancer

2007

Seminar, Dept. of Pharmacology, UofL
Human DNA polymerase f] is error-free when bypassing UV
photoproducts but error-prone when bypassing
benzo{ajpyrene adducts in vivo.

2007

Seminar, Student Meeting of the Ohio Valley Society of
Toxicology, Louisville, KY
Human DNA polymerase f] is error-free when bypassing UV
photoproducts but error-prone when bypassing
benzo{ajpyrene adducts in vivo.

2007

151 Place Poster, Basic Science Masters Student,
Research! Louisville, UofL
DNA polymerase eta is the preferred translesion DNA
polymerase and may be error-free or error-prone: evidence
from mutation spectra.

2007

Poster Presenter, Ohio Valley Society of Toxicology Annual
Meeting, Indianapolis, IN
Polf] and Poll are Required for Mutagenic Bypass of BPDE
Lesions in Primary Murine Fibroblasts

2007

Poster Presenter, JG Brown Cancer Center Annual Retreat,
Louisville, KY
Polf] and Polt are Required for MutageniC Bypass of BPDE
Lesions in Primary Murine Fibroblasts
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National/International

2007

2008

Platform Presentation, Environmental Mutagen Soc. National
Meeting, Atlanta, GA
Evidence from Mutation Spectra that DNA Polymerase eta is
the Preferred Translesion DNA Polymerase and May Be ErrorFree or Error-Prone
Platform Presentation, Environmental Mutagen Soc. National
Meeting, Rio Grande, Puerto Rico
Cell Death and Cell Cycle Pathways as Potential Targets for
Tumor Suppression by Pol Iota: A Systems Biology Approach

RESEARCH

1. FUNDING
Current Grant
Support:
Role in Project

Years

Grant Source

Grant Title

and % of Effort

Inclusive

NIEHS

U of L
Environmental
Health Sciences
Training Program
T32

T32
Fellow

12/2007 11/2008

ES011564

100%

2. LIST of CURRENT RESEARCH INTERESTS:
a.

Understand the cellular roles played by Y family polymerases in
response to structurally varied DNA adducts
b. Utilize emerging nanotechnologies to develop targeted markers for
imaging and treatment of skin and lung cancer.
c. Investigate the therapeutic effects of arsenic in mouse models of UVinduced skin cancer.

COMMUNITY INVOLVEMENT

Co-Captain, OneCorps Activist Group, Louisville, KY
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2006 - Present

